Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 20.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,660 shares of the company’s stock after selling 8,114 shares during the quarter. ProShare Advisors LLC’s holdings in Option Care Health were worth $849,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Parallel Advisors LLC boosted its position in shares of Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after purchasing an additional 478 shares during the period. TFO Wealth Partners LLC lifted its stake in Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after buying an additional 985 shares in the last quarter. Park Place Capital Corp boosted its holdings in shares of Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares during the period. Blue Trust Inc. increased its position in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in shares of Option Care Health during the first quarter valued at approximately $85,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on OPCH. Barrington Research lifted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. JMP Securities started coverage on Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 target price for the company.

Insider Buying and Selling at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH opened at $31.42 on Friday. The company has a market capitalization of $5.46 billion, a PE ratio of 20.67, a PEG ratio of 2.42 and a beta of 1.29. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The company’s 50 day moving average price is $31.29 and its 200 day moving average price is $30.42. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $34.63.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The business had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the company posted $0.63 EPS. Option Care Health’s revenue was up 14.8% on a year-over-year basis. Research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.